MINNEAPOLIS, July 17, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that it has completed its previously announced acquisition of all of the issued and outstanding limited liability company membership interests of FarmX, LLC d/b/a PhytoNatural ('PhytoNatural'), jointly with Vive Penn, LLC ('Vive'), a joint venture between the Company and Hive Holdings, Inc., pursuant to the previously announced Securities Purchase Agreement (the 'SPA') (the 'PhytoNatural Transaction').

明尼阿波利斯，2026年7月17日（环球电讯社）——Vireo Growth Inc.（CSE: VREO）（OTCQX: VREOF）（“Vireo”或“公司”）今日宣布，已根据此前公布的证券购买协议（“SPA”），完成了对FarmX, LLC（经营名称为PhytoNatural，“PhytoNatural”）所有已发行和存续的有限责任公司会员权益的收购。该交易由公司与其与Hive Holdings, Inc.的合资企业Vive Penn, LLC（“Vive”）共同进行（“PhytoNatural交易”）。

The acquisition includes a non-operational Pennsylvania medical cannabis retail permit that, subject to applicable regulatory approvals, authorizes the operation of up to six dispensaries in the Commonwealth..

此次收购包括一项宾夕法尼亚州的非运营医用大麻零售许可证，在获得适用的监管批准后，该许可证授权在宾夕法尼亚州运营最多六家 dispensaries。

Total consideration for the PhytoNatural Transaction was $20.0 million, consisting of $8.0 million paid in cash by Vive at closing and approximately $12.0 million payable through the issuance of approximately 645,161 Vireo subordinate voting shares at a deemed issue price of $18.60 per share, to be issued two years following the closing date, in accordance with the terms of the SPA..

PhytoNatural 交易的总对价为 2,000 万美元，包括 Vive 在交割时以现金支付的 800 万美元，以及根据《股份购买协议》（SPA）条款，在交割日两年后以每股 18.60 美元的 deemed 发行价格发行约 645,161 股 Vireo 次级投票权股份，从而应付的约 1,200 万美元。

About Vireo Growth Inc.

关于 Vireo Growth Inc.

Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) is a leading vertically integrated cannabis company building a broad platform across cannabis and adjacent agricultural markets. The Company operates cultivation, manufacturing, retail dispensaries, home delivery, distribution, and agricultural supply businesses across the United States, creating exposure to both cannabis and complementary adjacent markets.

Vireo Growth Inc.（CSE: VREO；OTCQX: VREOF）是一家领先的垂直整合大麻公司，正在构建一个跨越大麻及相邻农业市场的广泛平台。该公司在美国经营种植、制造、零售药房、送货上门、分销以及农业供应业务，从而同时涉足大麻市场及其互补的相邻市场。

With operations in 10 states and more than 170 dispensaries nationwide, Vireo combines disciplined capital allocation, strategic acquisitions, and local market execution to scale its platform and drive long-term shareholder value. The Company is focused on expanding market share and strengthening its portfolio of consumer brands and services, while supporting the customers, employees, shareholders, and communities it serves.

Vireo 的业务遍布美国10个州，在全国拥有超过170家 dispensaries（大麻零售店），通过纪律严明的资本配置、战略性收购和本地市场执行，扩大其平台规模并推动长期股东价值。公司专注于扩大市场份额，加强其消费者品牌和服务组合，同时支持其所服务的客户、员工、股东和社区。

For more information about Vireo, visit .

有关 Vireo 的更多信息，请访问。

www.vireogrowth.com

www.vireogrowth.com

.

。

Forward-Looking Information

前瞻性信息

This press release contains “forward-looking information” or “forward-looking statements” within the meaning of applicable United States and Canadian securities legislation (referred to herein as “forward-looking information”). To the extent any forward-looking information in this press release constitutes “financial outlooks” within the meaning of applicable United States or Canadian securities laws, this information is being provided as preliminary financial results; the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks.

本新闻稿包含适用美国和加拿大证券立法所定义的“前瞻性信息”或“前瞻性陈述”（以下简称“前瞻性信息”）。若本新闻稿中的任何前瞻性信息构成适用美国或加拿大证券法律所定义的“财务展望”，则该等信息仅作为初步财务结果提供；提醒读者，该等信息可能不适用于任何其他目的，读者不应过度依赖此类财务展望。

Forward-looking information contained in this press release may be identified by the use of words such as “should,” “believe,” “estimate,” “would,” “looking forward,” “may,” “continue,” “expect,” “expected,” “will,” “likely,” “subject to,” and variations of such words and phrases, or any statements or clauses containing verbs in any future tense and includes statements regarding expectations around the PhytoNatural Transaction and its expected benefits; the approximate value of the consideration to be paid in the transaction; and the Company’s expectations around integration of the operations of its recent acquisitions and timing thereof.

本新闻稿中包含的前瞻性信息可通过使用“应该”、“相信”、“估计”、“将会”、“展望”、“可能”、“继续”、“预期”、“预计”、“将”、“很可能”、“取决于”等词语及其变体，或任何包含将来时态动词的陈述或条款来识别，其中包括有关对PhytoNatural交易及其预期收益的期望；交易中拟支付对价的大致价值；以及公司对其近期收购业务整合及整合时间表的预期。

These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release.

上述陈述不应被视为对未来业绩或结果的保证。前瞻性信息包括已知和未知的风险、不确定性及其他因素，这些因素可能导致公司或其子公司的实际结果、业绩或成就与本新闻稿中前瞻性陈述或信息所明示或暗示的任何未来结果、业绩或成就存在重大差异。

Forward-looking information is based upon a n.

前瞻性信息基于一个 n。

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, the reader should not place undue reliance on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements.

尽管本公司认为，此类前瞻性信息所依据的预期和假设是合理的，但读者不应过度依赖该等前瞻性信息，因为本公司无法保证这些预期和假设将被证实为正确。实际结果和发展可能与这些陈述所预测的情况存在重大差异。

Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to: risks related to receipt of necessary approvals to operate dispensaries acquired in the PhytoNatural Transaction; risks and uncertainties associated with the integration of the PhytoNatural Transaction, some of which are beyond the Company’s control; the Company’s ability to maintain relationships with suppliers, customers, employees and other third parties as a result of the PhytoNatural Transaction; the effects of the proposed PhytoNatural Transaction on the Company and the interests of various constituents; the nature, cost, impact and outcome of pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions; risks related to the timing and content of adult-use legislation in markets where the Company currently operates; current and future market conditions, including the market price of the subordinate voting shares of the Company; risks related to epidemics and pandemics; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations in the United States and any ch.

前瞻性信息受多种风险和不确定性的影响，这些风险和不确定性可能导致实际事件或结果与前瞻性信息中预测的情况存在重大差异。此类风险和不确定性包括但不限于：与获得在PhytoNatural交易中收购的 dispensary（零售店）运营所需批准相关的风险；与PhytoNatural交易整合相关的风险和不确定性，其中部分超出公司控制范围；由于PhytoNatural交易，公司维持与供应商、客户、员工及其他第三方关系的能力；拟议的PhytoNatural交易对公司及各利益相关方权益的影响；未决及未来诉讼、其他法律或监管程序、或政府调查和行动的性质、成本、影响和结果；与公司目前运营市场中成人使用大麻立法的时间和内容相关的风险；当前及未来的市场状况，包括公司次级投票股的市场价格；与流行病和大流行病相关的风险；联邦、州、地方及外国政府的法律、规则和法规，包括美国联邦和州关于美国境内大麻业务的法律和法规，以及任何ch。

www.sec.gov

www.sec.gov

and filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at

并已提交给加拿大证券监管机构，可在SEDAR+上的公司资料中查阅，网址为

www.sedarplus.com

www.sedarplus.com

.

。

The statements in this press release are made as of the date of this release. Except as required by law, we undertake no obligation to update any forward-looking statements or forward-looking information to reflect events or circumstances after the date of such statements.

本新闻稿中的陈述截至本新闻稿发布之日作出。除法律要求外，我们不承担任何义务更新任何前瞻性陈述或前瞻性信息，以反映此类陈述日期之后发生的事件或情况。

Contact Information:

联系方式：

Lynn Ricci

林恩·里奇

Director Investor Relations & Corporate Communications

投资者关系与企业传播总监

investor@vireogrowth.com

investor@vireogrowth.com

(612) 314-8995

(612) 314-8995